# Study in Healthy Males to Measure Darunavir and Etravirine in Blood, Seminal Fluid, and Rectal Tissue

> **NCT00855088** · PHASE1 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 13 (actual)

## Conditions studied

- HIV/AIDS
- HIV Infections

## Interventions

- **DRUG:** darunavir
- **DRUG:** Ritonavir
- **DRUG:** Etravirine

## Key facts

- **NCT ID:** NCT00855088
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2010-02
- **Final completion:** 2011-02
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2011-05-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00855088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00855088, "Study in Healthy Males to Measure Darunavir and Etravirine in Blood, Seminal Fluid, and Rectal Tissue". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00855088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*